• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Maternal chronic conditions increase risk of cerebral palsy among offspring

byLuv Makadia, MDandAlex Gipsman, MD
February 18, 2021
in Neurology, Obstetrics, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Maternal chronic conditions (particularly autoimmune conditions) such as type 1 and 2 diabetes, rheumatoid arthritis, and migraines were associated with a higher risk of cerebral palsy in offspring.

2. There was a stronger association of cerebral palsy risk with maternal chronic conditions recorded at delivery, as compared to maternal chronic conditions recorded in the patient registry, which may have occurred after pregnancy.

Evidence Rating Level: 2 (Good)

Study Rundown: Maternal prenatal conditions that cause an inflammatory state are thought to contribute toward the development of cerebral palsy among offspring. However, previous studies that have looked at maternal chronic conditions and the risk of cerebral palsy have lacked power and have typically only looked at one to two maternal chronic conditions. This study used national health registries in Norway to look at the association between various maternal chronic conditions and the development of cerebral palsy. Maternal chronic conditions (particularly autoimmune conditions) such as type 1 and 2 diabetes, rheumatoid arthritis, and migraines were associated with a statistically significant higher risk of cerebral palsy in offspring, with an even greater risk in mothers with multiple chronic and/or autoimmune conditions. Additionally, there was a stronger association of cerebral palsy risk with maternal chronic conditions recorded at delivery, as compared to maternal chronic conditions recorded in the patient registry, which may have occurred after pregnancy. Chronic conditions in fathers showed no association with the development of offspring cerebral palsy, suggesting that the development of cerebral palsy is unlikely to be as a result of genetic factors. Because the present study linked individual data from multiple national registries, it allowed for a robust analysis. However, certain confounding factors like maternal BMI, which is a known contributor toward cerebral palsy, were not controlled for. The results of this study further solidify the link between maternal inflammatory states and the development of cerebral palsy among offspring.

Click to read the study, published today in Pediatrics

Relevant Reading: Perinatal Factors Associated With Cerebral Palsy in Children Born in Sweden

RELATED REPORTS

The Scan by 2 Minute Medicine®: Leucovorin autism update, Oura Ring FDA scrutiny, Lilly oral GLP-1 trial, and Florida vaccine mandate repeal

Tylenol in the Spotlight: Pregnancy, Autism, and Evolving Guidance on Acetaminophen use

Pre-conception computed tomography ionizing radiation may be associated with worse reproductive outcomes

In-Depth [retrospective cohort]: To understand the association of maternal chronic conditions and the development of cerebral palsy among offspring, this study carried out a cohort study using various Norwegian health registries. A total of 1,360,149 children met the inclusion criteria of birth from 1990 – 2012 who survived to at least 2 years old and having information on maternal chronic conditions from the birth registry. 3,575 of these children had cerebral palsy. The primary outcome measure was diagnosis of cerebral palsy, defined as those who received disability compensation based on a cerebral palsy diagnosis or those that were at least twice recorded in the patient registry with a cerebral palsy diagnosis. The study found that mothers with any chronic condition were more likely to have offspring with cerebral palsy (RR 1.3; 95% CI 1.2–1.5). The relative risk of offspring cerebral palsy was 1.3 (95% CI 1.1–1.4) with any single condition, 1.6 (95% CI 1.1–2.4) with two conditions, and 3.4 (95% CI 1.5–7.7) with ≥ 3 conditions. Specific conditions which showed a statistically significant association with offspring developing cerebral palsy include type 2 diabetes (RR 3.2; 95% CI 1.8–5.4), type 1 diabetes (RR 2.2; 95% CI 1.4–3.4), rheumatoid arthritis (RR 2.0; 95% CI 1.3–2.9), and migraine (RR 1.6; 95% CI 1.2–2.2). There was a relative risk of 1.4 (95% CI 1.1–1.6) with any maternal autoimmune disease. The relative risk was 1.4 (95% CI 1.1–1.7) with any single maternal autoimmune disease and 2.7 (95% CI 1.1–6.6) with ≥ 2 maternal autoimmune diseases.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cerebral palsy (CP)pregnancy
Previous Post

Bimekizumab is tolerable and efficacious for patients with moderate to severe plaque psoriasis

Next Post

Progression of COVID-19 reduced after high-titer convalescent plasma administration

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Obstetrics

The Scan by 2 Minute Medicine®: Leucovorin autism update, Oura Ring FDA scrutiny, Lilly oral GLP-1 trial, and Florida vaccine mandate repeal

September 25, 2025
Majority of pediatric medication-related visits to emergency department are preventable
Career Development

Tylenol in the Spotlight: Pregnancy, Autism, and Evolving Guidance on Acetaminophen use

September 25, 2025
Half of parents aware of CT radiation cancer risk
Obstetrics

Pre-conception computed tomography ionizing radiation may be associated with worse reproductive outcomes

September 8, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

August 22, 2025
Next Post
SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Progression of COVID-19 reduced after high-titer convalescent plasma administration

#VisualAbstract: Nivolumab plus ipilimumab increases overall survival in patients with malignant pleural mesothelioma

#VisualAbstract: Enfortumab vedotin prolongs survival in previously treated advanced urothelial carcinoma

#VisualAbstract Bortezomib, cyclophosphamide, and dexamethasone demonstrated a modest median event-free survival in transplant ineligible patients with multiple myeloma

#VisualAbstract Bortezomib, cyclophosphamide, and dexamethasone demonstrated a modest median event-free survival in transplant ineligible patients with multiple myeloma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Acute Surgery vs Conservative Treatment for Traumatic Acute Subdural Hematoma
  • Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis
  • Juror perception of radiologist liability can be affected by artificial intelligence (AI) use in diagnosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.